Mutations in JAK2 and in the MPN driver genes, myeloproliferative leukemia virus (MPL) and calreticulin (CALR), upregulate JAK‐STAT signaling with increased downstream transcription and gene expression. This evidence concerns the gene CALR and myeloproliferative neoplasm.